Select a REGIMEN:

A+D(7+3)(INDUCTION)
A+D+E(7+3+7)(INDUCTION)
HiDAC
IDA-AR 1 (INDUCTION)
IDA-AR 2 (CONSOLIDATION)
MC (INDUCTION)

REGIMEN: A+D(7+3)(INDUCTION)

CYTARABINE [ARA-C] 100 mg/m2 per day x 7 CIV...D1-7

DAUNORUBICIN [DNR] 45 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity) Note: Repeat for further induction or consolidation with cytarabine x 5 days and daunorubicin x 2 days

DISEASE: Acute Myelogenous

REGIMEN: A+D+E(7+3+7)(INDUCTION)

CYTARABINE [ARA-C] 100 mg/m2 per day CIV...D1-7

DAUNORUBICIN [DNR] 50 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity)

ETOPOSIDE [VP-16] 75 mg/m2 per day IV/1 hr...D1-7

DISEASE: Acute Myelogenous

REGIMEN: HiDAC

CYTARABINE [ARA-C] 1.5 - 3 g/m2 IV/12 h
x 4-6 days

DISEASE: Acute Myelogenous

REGIMEN: IDA-AR 1 (INDUCTION)

IDARUBICIN [IDA] 12 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity)

CYTARABINE [ARA-C] 100 mg/m2 per day x 7 CIV...D1-7

DISEASE: Acute Myelogenous

REGIMEN: IDA-AR 2 (CONSOLIDATION)

THIOGUANINE [6-TG] 100 mg/m2 PO q 12h
x 10 doses

CYTARABINE [ARA-C] 100 mg/m2 IV q 12h
x 10 doses

IDARUBICIN [IDA] 15 mg/m2 IV...D1
Caution: Monitor cumulative dose (cardiac toxicity)

DISEASE: Acute Myelogenous

REGIMEN: MC (INDUCTION)

MITOXANTRONE [DHAD] 12 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity)

CYTARABINE [ARA-C] 100 mg/m2 per day x 7 CIV...D1-7

Medicine OnLine and UltiTech have no liability for content or goods on the Internet except as set forth in the Terms and Conditions of service. Please read the Disclaimer of Warranties before using information contained in this section. © Copyright 1995-2000 UltiTech, Inc. All Rights Reserved.